Clarivate Inks Pact With HealthWise Data To Boost Real-World Data Offering; Collaboration Enhances Patient Demographics Insight, Enabling Analytical Precision In Population Health Outcomes

5/31/24 3:50:26 AM ET

EDP Services

Technology

Get the next $CLVT alert in real time by email

Clarivate announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap between clinical outcomes and Social Determinants of Health (SDoH) domains. The collaboration integrates SDoH attributes into the Clarivate Real-World Data repository, offering comprehensive patient insights and enabling life science, healthcare and research professionals to enhance patient outcomes and healthcare equity.

Get the next $CLVT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CLVT

Date	Price Target	Rating	Analyst
11/6/2024		Outperform → Mkt Perform	William Blair
12/15/2023	$8.00	Equal Weight → Underweight	Wells Fargo
10/16/2023	$10.00 → $8.50	Hold → Buy	Jefferies
9/8/2023	$8.00 → $7.00	Equal Weight → Underweight	Barclays
8/25/2023	$9.00 → $8.00	Outperform → Sector Perform	RBC Capital Mkts
8/7/2023	$10.00 → $6.00	Neutral → Underperform	BofA Securities
8/4/2023	$15.00 → $8.00	Overweight → Equal Weight	Wells Fargo
6/13/2023	$11.00	Outperform	Oppenheimer

More analyst ratings

$CLVT
Press Releases

Fastest customizable press release news feed in the world

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the Health Divide.' This seven-part series sheds light on the persistent disparities in women's health research, funding, and treatment. Women make up half of the global population, yet their health remains consistently underserved. Research and treatments have traditionally fo
11/21/24 3:00:00 AM ET
$CLVT
EDP Services
Technology
Clarivate Reveals Highly Cited Researchers 2024 List
Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON, Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. Analysts at the Institute for Scientific Information (ISI)™ have recognized 6,636 Highly Cited Researche
11/19/24 3:00:00 AM ET
$CLVT
EDP Services
Technology
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON, Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come. Over the past decade, Mainland China's biopharmaceutical sector has rapidly advanced to become a global leader in innovation, rankin
11/18/24 3:00:00 AM ET
$CLVT
EDP Services
Technology

$CLVT
Financials

Live finance-specific insights

Clarivate Reports Third Quarter 2024 Results
LONDON, Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Revenues of $622.2 million decreased 3.9%Organic revenues decreased 2.6%, as an increase in subscription revenues of 0.6% was offset by a decrease in re-occurring revenues of 1.1% and transactional and other revenues of 13.6%Net loss of $65.6 million; Net loss per diluted share of $0.09Adjusted net income(1) of $134.1
11/6/24 6:00:00 AM ET
$CLVT
EDP Services
Technology
Clarivate to Report Third Quarter 2024 Results on November 6, 2024
LONDON, Oct. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third quarter 2024 before the market opens on Wednesday, November 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, November 6, 2024 to review the results. The webcast is open to all in
10/16/24 8:30:00 AM ET
$CLVT
EDP Services
Technology
Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company's Next CEO
Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company's next CEO, effective August 9, 2024. Mr. Shem Tov will also join the Company's Board of Directors. Jonathan Gear, Chief Executive Officer, will step down as CEO and as a member of the Board at that time, and will transition into a non-executive role until November 1, 2024. "The Board
8/6/24 6:01:00 AM ET
$CLVT
EDP Services
Technology

$CLVT
Market Insights

Live Market Insights

Clarivate Acquires Rowan TELS Corp. Through Subsidiary; No Terms Disclosed
Rowan TELS Corp. is the provider of Rowan Patents – an integrated patent drafting and prosecution solution specially designed for patent practitioners to establish and protect patents more effectively.
7/22/24 6:04:58 AM ET
$CLVT
EDP Services
Technology
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
These eleven mid-cap stocks were the best performers in the last week. Are they in your portfolio? Virtu Financial, Inc. (NASDAQ:VIRT) shares jumped 30.04% after reporting better-than-expected Q2 financial results. V.F. Corporation (NYSE:VFC) stock upped 22.38% after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica (OTC: ESLOF) for $1.5 billion in cash. Several analysts raised their price forecasts on VFC. New Fortress Energy Inc. (NASDAQ:NFE) shares grew 20.19% after the company announced that it achieved First LNG for its initial Fast LNG asset located offshore Altamira, Mexico. Riot Platforms Inc (NASDAQ:
7/21/24 12:07:27 PM ET
$AMN
$BKU
$CLVT
$EXPI
Professional Services
Consumer Discretionary
Savings Institutions
Finance
Clarivate and Ohio Libraries Partner to Enhance Resource Sharing by 2025
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a partnership with OhioLINK, Ohio's academic library consortium, and SearchOhio, a consortium of Ohio public libraries, to develop a new library resource sharing consortial experience. Through this partnership Clarivate will unify OhioLINK and SearchOhio's resource sharing platforms to enhance library user experiences and services, improve operational efficiencies and build upon existing consortia collaboration. The new solution is expected to be implemented by mid-year in 2025. The new solution will integrate OhioLINK and SearchOhio's existing INN-Reach platforms, part of Innovative™, i
7/18/24 3:04:20 AM ET
$CLVT
EDP Services
Technology

$CLVT
Leadership Updates

Live Leadership Updates

Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare
Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,
4/26/23 7:00:00 AM ET
$CLVT
EDP Services
Technology
Clarivate Names Bar Veinstein as President, Academia & Government
Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader
4/19/23 7:00:00 AM ET
$CLVT
EDP Services
Technology
Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director
Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.
3/23/23 4:30:00 PM ET
$CLVT
$CNTA
EDP Services
Technology
Biotechnology: Pharmaceutical Preparations
Health Care

Clarivate Inks Pact With HealthWise Data To Boost Real-World Data Offering; Collaboration Enhances Patient Demographics Insight, Enabling Analytical Precision In Population Health Outcomes

Chat with this insight

Recent Analyst Ratings for $CLVT

$CLVT Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Snyder Andrew Miles bought $1,644,410 worth of Ordinary Shares (290,938 units at $5.65) (SEC Form 4)

$CLVT Press Releases

Fastest customizable press release news feed in the world

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series

Clarivate Reveals Highly Cited Researchers 2024 List

New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence

$CLVT Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Clarivate downgraded by William Blair

Clarivate downgraded by Wells Fargo with a new price target

Clarivate upgraded by Jefferies with a new price target

$CLVT Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Clarivate Plc

SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

SEC Form SC 13G/A filed by Clarivate Plc (Amendment)

$CLVT SEC Filings

SEC Form 10-Q filed by Clarivate Plc

Clarivate Plc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

Clarivate Plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

$CLVT Financials

Live finance-specific insights

Clarivate Reports Third Quarter 2024 Results

Clarivate to Report Third Quarter 2024 Results on November 6, 2024

Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company's Next CEO

$CLVT Market Insights

Live Market Insights

Clarivate Acquires Rowan TELS Corp. Through Subsidiary; No Terms Disclosed

Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?

Clarivate and Ohio Libraries Partner to Enhance Resource Sharing by 2025

$CLVT Leadership Updates

Live Leadership Updates

Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

Clarivate Names Bar Veinstein as President, Academia & Government

Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

$CLVT Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Senior VP, Finance/CAO Easton Michael M was granted 115,473 units of Ordinary Shares, increasing direct ownership by 45% to 372,887 units (SEC Form 4)

President, A&G Veinstein Bar sold $420,000 worth of Ordinary Shares (60,000 units at $7.00), decreasing direct ownership by 6% to 916,583 units (SEC Form 4)

Director Bomba Jane L Okun covered exercise/tax liability with 116 units of Ordinary Shares and was granted 4,049 units of Ordinary Shares, increasing direct ownership by 3% to 157,286 units (SEC Form 4)

Recent Analyst Ratings for
$CLVT

$CLVT
Insider Purchases

$CLVT
Press Releases

$CLVT
Analyst Ratings

$CLVT
Large Ownership Changes

$CLVT
SEC Filings

$CLVT
Financials

$CLVT
Market Insights

$CLVT
Leadership Updates

$CLVT
Insider Trading